This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
price-performance: Archive
Moderna (MRNA) Soars 8.7%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
MRNANegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Why Abercrombie (ANF) Might be Well Poised for a Surge
by Zacks Equity Research
Abercrombie (ANF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ANFNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Recent Price Trend in Ezcorp (EZPW) is Your Friend, Here's Why
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Ezcorp (EZPW) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
EZPWNegative Net Change
price-performance stock-price-change stock-price-movement
American Superconductor (AMSC) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
American Superconductor (AMSC) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
AMSCNegative Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Blachem (BCPC) Should Keep going
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Blachem (BCPC) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
BCPCNegative Net Change
price-performance stock-price-change stock-price-movement
Nitto Denko Corp. (NDEKY) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Nitto Denko Corp. (NDEKY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
NDEKYNegative Net Change
price-performance stock-price-change stock-price-movement
Can Krystal Biotech, Inc. (KRYS) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Krystal Biotech, Inc. (KRYS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
KRYSNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for Zuora (ZUO) Stock
by Zacks Equity Research
Zuora (ZUO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ZUOPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why Cadre Holdings, Inc. (CDRE) Might be Well Poised for a Surge
by Zacks Equity Research
Cadre Holdings, Inc. (CDRE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CDRENegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Recent Price Trend in Knife River (KNF) is Your Friend, Here's Why
by Zacks Equity Research
Knife River (KNF) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
KNFNegative Net Change
price-performance stock-price-change stock-price-movement
Here's Why 'Trend' Investors Would Love Betting on Sabesp (SBS)
by Zacks Equity Research
Sabesp (SBS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
SBSNegative Net Change
price-performance stock-price-change stock-price-movement
HNI (HNI) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, HNI (HNI) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
HNINegative Net Change
price-performance stock-price-change stock-price-movement
Here's Why 'Trend' Investors Would Love Betting on Citizens Community Bancorp, Inc. (CZWI)
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Citizens Community Bancorp, Inc. (CZWI) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
CZWINo Net Change
price-performance stock-price-change stock-price-movement
Here's What Could Help Nomura (NMR) Maintain Its Recent Price Strength
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Nomura (NMR) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
NMRNegative Net Change
price-performance stock-price-change stock-price-movement
Recent Price Trend in Suzano S.A. Sponsored ADR (SUZ) is Your Friend, Here's Why
by Zacks Equity Research
Suzano S.A. Sponsored ADR (SUZ) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
SUZPositive Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Lyra Therapeutics, Inc. (LYRA) Should Keep going
by Zacks Equity Research
Lyra Therapeutics, Inc. (LYRA) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
LYRANegative Net Change
price-performance stock-price-change stock-price-movement
Here's What Could Help Natura &Co Holding S.A. ADR (NTCOY) Maintain Its Recent Price Strength
by Zacks Equity Research
Natura &Co Holding S.A. ADR (NTCOY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
NTCOYNo Net Change
price-performance stock-price-change stock-price-movement
Strength Seen in ArcBest (ARCB): Can Its 6.0% Jump Turn into More Strength?
by Zacks Equity Research
ArcBest (ARCB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
ARCBNegative Net Change SAIANegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Can iQIYI, Inc. Sponsored ADR (IQ) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
iQIYI, Inc. Sponsored ADR (IQ) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
IQPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Rising for Enact Holdings, Inc. (ACT): Will It Gain?
by Zacks Equity Research
Enact Holdings, Inc. (ACT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ACTNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Vertex (VERX): Time to Buy?
by Zacks Equity Research
Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
VERXNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Northrim (NRIM): Time to Buy?
by Zacks Equity Research
Northrim (NRIM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
NRIMNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Cincinnati Financial (CINF) Soars 5.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Cincinnati Financial (CINF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CINFPositive Net Change PGRNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Here's What Could Help Modine (MOD) Maintain Its Recent Price Strength
by Zacks Equity Research
Modine (MOD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
MODNegative Net Change
price-performance stock-price-change stock-price-movement
Virtus (VRTS) Soars 8.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Virtus (VRTS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
VRTSPositive Net Change AMPPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today